PTEN: a new twist on β-catenin?
- 1 March 2002
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 23 (3), 104-106
- https://doi.org/10.1016/s0165-6147(00)01984-2
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Integrin-linked kinase (ILK) and its interactorsThe Journal of cell biology, 2001
- Tumor Suppressor Pten Inhibits Nuclear Accumulation of β-Catenin and T Cell/Lymphoid Enhancer Factor 1–Mediated Transcriptional ActivationThe Journal of cell biology, 2001
- Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBβ)Science, 2001
- PTEN: Life as a Tumor SuppressorExperimental Cell Research, 2001
- Differential Regulation of Glycogen Synthase Kinase 3β by Insulin and Wnt SignalingJournal of Biological Chemistry, 2000
- Genetic control of cell sizeCurrent Opinion in Genetics & Development, 2000
- Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cellsProceedings of the National Academy of Sciences, 2000
- Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTENCell, 1998
- Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancersNature Genetics, 1997
- PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate CancerScience, 1997